Evidence map›Paper›PMID 38481694›Full record

ArticleACS pharmacology & translational science2024

Improved Methodology for Evaluating Nanomedicine Antibacterial Properties in Biological Fluids.

Ali Akbar Ashkarran, Shahriar Sharifi, Christopher N LaRock, Morteza Mahmoudi

Open access · hybridAbstract read
In one paragraph

Article in ACS pharmacology & translational science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 55% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Ali Akbar AshkarranDepartment of Radiology and Precision Health Program, Michigan State University, East Lansing, Michigan 48824, United States.
Shahriar SharifiDepartment of Radiology and Precision Health Program, Michigan State University, East Lansing, Michigan 48824, United States.ORCID https://orcid.org/0000-0002-3853-5428
Christopher N LaRockDepartment of Microbiology and Immunology, Emory Antibiotic Resistance Center, Emory University School of Medicine, Atlanta, Georgia 30322, United States.ORCID https://orcid.org/0000-0003-3035-5331
Morteza MahmoudiDepartment of Radiology and Precision Health Program, Michigan State University, East Lansing, Michigan 48824, United States.ORCID https://orcid.org/0000-0002-2575-9684
Michigan State University · USEmory University · US

Funding

A Nanostructured Skin Patch to Heal Chronic WoundsR01DK131417 · NIDDK · MICHIGAN STATE UNIVERSITY · PI Morteza Mahmoudi · 2022 to 2026
$2.0M
NIDDK NIH HHS R01 DK131417
6 · The paper itself

Abstract

Accurate assessment of nanomedicines' antibacterial properties is pivotal for their effective use in both

Identifiers

PMID38481694
PMCPMC10928882
OpenAlexW4391815475

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.